Effectiveness of direct delabelling of allergy labels in type A adverse drug reactions to penicillin: a multicentre hospitalwide prospective cohort study

Drummond, K; Vogrin, S; Lambros, B; Trubiano, JA; Mitri, E

Author(s): Drummond, K; Vogrin, S; Lambros, B; Trubiano, JA; Mitri, E;
Details: Publication Year 2024-10-01,Volume 79,Issue #10,Page 2640-2644
Journal Title: Journal of Antimicrobial Chemotherapy
Publication Type: Research article
Abstract: BACKGROUND: Patient-reported penicillin allergy labels (PALs) are associated with adverse patient outcomes and inappropriate antibiotic prescribing. Removal of PALs via direct oral challenge (DOC) is associated with increased penicillin utilization post removal. OBJECTIVES: To assess the impact of direct delabelling (allergy label removal via medical reconciliation alone) of type A adverse drug reaction (ADR) PALs on inpatient prescribing. METHODS: From January 2019 to December 2022 at two tertiary hospitals in Melbourne, patients aged ≥18 years with type A ADR PALs, as defined by the validated Antibiotic Allergy Assessment Tool, were offered direct delabelling or single-dose DOC. The primary endpoint was antibiotic use pre- and post-assessment (during index admission and 90 days post assessment). The secondary endpoint was the proportion of patients delabelled in the direct delabelling and DOC cohorts in the electronic medical record at 90 days post assessment. RESULTS: Allergy labels (n = 4108) were assessed for 488 participants, with 490 individual type A ADR PAL assessments included. Three hundred and thirty-seven patients were directly delabelled, 69 underwent DOC and 84 were not delabelled. There was increased use of any penicillin following direct delabelling (OR 19.19, 95% CI 2.48-148.36) and DOC (OR 56.98, 95% CI 6.82-476.19) during the index admission, higher in the DOC group compared with direct delabelling (OR 2.97, 95% CI 1.39-6.37). Relabelling at 90 days was low with no statistically significant difference between direct delabelling (5/337; 1.5%) and DOC (0/69; 0%). CONCLUSIONS: Both direct delabelling and DOC of type A ADR PALs increased penicillin usage; however, the impact was greatest with DOC. Most patients remain delabelled at 90 days.
Publisher: Oxford University Press
Keywords: Humans; *Penicillins/adverse effects; *Drug Hypersensitivity/etiology; Male; Prospective Studies; Female; Middle Aged; *Anti-Bacterial Agents/adverse effects; Aged; *Drug Labeling; Adult; Tertiary Care Centers; Australia
Department(s): Health Services Research
Publisher's Version: https://doi.org/10.1093/jac/dkae270
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2024-10-03 03:37:15

Last Modified: 2024-10-03 03:37:33